Founded in 1988, Putnam Associates has been serving global biopharmaceutical, diagnostics, and medical device clients, along with private equity and venture capital clients, providing world class strategic advice based on sophisticated, robust analytics. Our focus enables us to provide customized, actionable recommendations that draw on robust problem framing, cutting-edge methodologies, deep therapeutic area knowledge, extensive global networks of health care stakeholders, and expert synthesis across scientific, clinical, and business disciplines. Our consultants have similar professional and educational backgrounds to those at generalist strategy consulting firms but with a significant advantage: 100% of Putnam’s work is dedicated to maximizing the value of the pharmaceutical, biotechnology, diagnostic and device products. We serve clients who market many of the world’s best-known biopharmaceuticals, and who are leveraging the genomics and “big data” revolutions month by month with new breakthrough therapies and higher quality patient care.
İş Başvuru Formu
Society where there is understanding
Our consultants have similar professional and educational backgrounds to those at generalist strategy consulting firms but with a significant advantage: 100% of Putnam’s work is dedicated to maximizing the value of the pharmaceutical, biotechnology, diagnostic and device products.
Just send us your questions and we will give you the help you need.
Our focus enables us to provide customized, actionable recommendations that draw.
Our focus enables us to provide customized, actionable recommendations that draw on robust problem framing, cutting-edge methodologies, deep therapeutic area knowledge, extensive global networks of health care stakeholders, and expert synthesis across scientific, clinical, and business disciplines.
Putnam’s work is dedicated to maximizing the value of the pharmaceutical, biotechnology, diagnostic and device products. We serve clients who market many of the world’s best-known biopharmaceuticals, and who are leveraging the genomics and “big data” revolutions month by month with new breakthrough therapies and higher quality patient care.
Bernie Clinton
FOUNDER